Saguaro Biosciences
Canada
- Quebec City
- 05/06/2024
- Seed
- $3,000,000
Saguaro offers next-generation cell culture products that help scientists improve drug discovery success.
ChromaLive is a first-of-a-kind non-toxic dye. It allows the generation of unique phenotypic signatures from microscopy images of cells, and the quantification of disease-relevant phenotypes like cellular apoptosis, stress, autophagy, and more. With its unique add-and-mix feature, ChromaLive is ideal for automation workflows, live cell painting, 3D cultures, weeks-long kinetic imaging, and patient-derived cells.
We are passionate about new technologies that can improve human health. We believe that by making disruptive technologies available to drug developers around the globe, new therapies will become available to patients at a faster pace.
- Industry Biotechnology
- Website https://www.saguarobio.com/
- LinkedIn https://www.linkedin.com/company/saguarobio/
WealthAi | $1,000,000 | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
Mesh Security | $12,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Co-reactive | $7,754,157 | (Jan 30, 2026)
Arkero | $6,000,000 | (Jan 30, 2026)
Redwood Materials | $425,000,000 | (Jan 30, 2026)
Twogee Biotech | $2,575,886 | (Jan 30, 2026)
Levellr | $2,500,000 | (Jan 30, 2026)
Indigo(1) | $50,000,000 | (Jan 30, 2026)
heyData | $16,500,000 | (Jan 30, 2026)